Zdrowie i gospodarka · 09/12/2003
Oncologic Drugs Advisory Committee; Amendment of Notice
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Oncologic Drugs Advisory Committee. This meeting was announced in the Federal Register of November 18, 2003 (68 FR 65076-65077). The amendment is being made to reflect a change in the Location portion of the document. There are no other changes.